Tag: ORGOVYX

Home / ORGOVYX

Categories

The FDA has approved relugolix for the treatment of advanced prostate cancer

August 2021: The first oral gonadotropin-releasing hormone (GnRH) receptor antagonist, relugolix (ORGOVYX, Myovant Sciences, Inc.), was approved by the Food and Drug Administration on December 18, 202...
orgovyx

We Are Online! Chat With Us!
Scan the code